image
Healthcare - Medical - Care Facilities - NYSE - US
$ 14.36
11.8 %
$ 1.23 B
Market Cap
-12.17
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one MD stock under the worst case scenario is HIDDEN Compared to the current market price of 14.4 USD, Pediatrix Medical Group, Inc. is HIDDEN

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one MD stock under the base case scenario is HIDDEN Compared to the current market price of 14.4 USD, Pediatrix Medical Group, Inc. is HIDDEN

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one MD stock under the best case scenario is HIDDEN Compared to the current market price of 14.4 USD, Pediatrix Medical Group, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart MD

image
$18.0$18.0$17.0$17.0$16.0$16.0$15.0$15.0$14.0$14.0$13.0$13.0$12.0$12.015 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '25
FINANCIALS
2.01 B REVENUE
0.92%
-68.7 M OPERATING INCOME
-938.57%
-99.1 M NET INCOME
-64.00%
207 M OPERATING CASH FLOW
50.43%
-35.4 M INVESTING CASH FLOW
26.51%
-14.5 M FINANCING CASH FLOW
43.67%
502 M REVENUE
-1.72%
39.3 M OPERATING INCOME
16.15%
30.5 M NET INCOME
56.78%
133 M OPERATING CASH FLOW
32.06%
-1.94 M INVESTING CASH FLOW
55.33%
-4.96 M FINANCING CASH FLOW
-61.61%
Balance Sheet Pediatrix Medical Group, Inc.
image
Current Assets 640 M
Cash & Short-Term Investments 349 M
Receivables 273 M
Other Current Assets 18.5 M
Non-Current Assets 1.51 B
Long-Term Investments 0
PP&E 78.4 M
Other Non-Current Assets 1.43 B
16.19 %12.66 %3.64 %66.64 %Total Assets$2.2b
Current Liabilities 434 M
Accounts Payable 46.4 M
Short-Term Debt 18.8 M
Other Current Liabilities 369 M
Non-Current Liabilities 954 M
Long-Term Debt 594 M
Other Non-Current Liabilities 360 M
3.35 %26.58 %42.77 %25.95 %Total Liabilities$1.4b
EFFICIENCY
Earnings Waterfall Pediatrix Medical Group, Inc.
image
Revenue 2.01 B
Cost Of Revenue 1.56 B
Gross Profit 454 M
Operating Expenses 523 M
Operating Income -68.7 M
Other Expenses 30.4 M
Net Income -99.1 M
3b3b2b2b2b2b1b1b500m500m00(500m)(500m)2b(2b)454m(523m)(69m)(30m)(99m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
22.57% GROSS MARGIN
22.57%
-3.41% OPERATING MARGIN
-3.41%
-4.92% NET MARGIN
-4.92%
-12.95% ROE
-12.95%
-4.60% ROA
-4.60%
-3.87% ROIC
-3.87%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Pediatrix Medical Group, Inc.
image
500m500m450m450m400m400m350m350m300m300m250m250m200m200m150m150m100m100m50m50m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -99.1 M
Depreciation & Amortization 33.2 M
Capital Expenditures -22 M
Stock-Based Compensation 11.9 M
Change in Working Capital 88.2 M
Others 201 M
Free Cash Flow 185 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Pediatrix Medical Group, Inc.
image
Wall Street analysts predict an average 1-year price target for MD of $11.2 , with forecasts ranging from a low of $8 to a high of $14 .
MD Lowest Price Target Wall Street Target
8 USD -44.29%
MD Average Price Target Wall Street Target
11.2 USD -21.66%
MD Highest Price Target Wall Street Target
14 USD -2.51%
Price
Max Price Target
Min Price Target
Average Price Target
181816161414121210108866Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 5
6. Ownership
Insider Ownership Pediatrix Medical Group, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
751 K USD 4
9-12 MONTHS
504 K USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Pediatrix Medical Group, Inc. (MD) Q1 2025 Earnings Call Transcript Pediatrix Medical Group, Inc. (NYSE:MD ) Q1 2025 Earnings Conference Call May 6, 2025 9:00 AM ET Company Participants Mark Ordan - Chief Executive Officer Kasandra Rossi - Chief Financial Officer Conference Call Participants A.J. Rice - UBS Philip Chickering - Deutsche Bank Jack Levin - Jefferies Operator [Abruptly Started] Certain statements and information during this conference call may be deemed to be forward-looking statements within the meaning of the Federal Private Securities Litigation Reform Act of 1995. seekingalpha.com - 1 week ago
Pediatrix Medical Group (MD) Q1 Earnings and Revenues Surpass Estimates Pediatrix Medical Group (MD) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.20 per share a year ago. zacks.com - 1 week ago
Pediatrix Medical Group Reports First Quarter Results FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports First Quarter Results. businesswire.com - 1 week ago
MD vs. HQY: Which Stock Should Value Investors Buy Now? Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and HealthEquity (HQY). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com - 2 weeks ago
Can Lower Expenses Save Pediatrix Medical's Q1 Earnings? MD's first-quarter results are likely to reflect declining hospital contract administrative fees. zacks.com - 2 weeks ago
Boost Your Portfolio With These 5 Low Price-to-Book Stocks The P/B ratio helps to identify low-priced stocks with high growth prospects. CNC, MD, PFE, STNE and SAN are some such stocks. zacks.com - 2 weeks ago
Here's Why Pediatrix Medical Group (MD) is a Strong Value Stock Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com - 3 weeks ago
Pediatrix Medical Group 2025 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 6, 2025 FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2025 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 6, 2025. businesswire.com - 4 weeks ago
MD or HQY: Which Is the Better Value Stock Right Now? Investors interested in Medical Services stocks are likely familiar with Pediatrix Medical Group (MD) and HealthEquity (HQY). But which of these two stocks is more attractive to value investors? zacks.com - 1 month ago
Why Pediatrix Medical Group (MD) is a Top Value Stock for the Long-Term Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com - 1 month ago
Here Is Why Bargain Hunters Would Love Fast-paced Mover Pediatrix Medical Group (MD) If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Pediatrix Medical Group (MD) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen. zacks.com - 1 month ago
MD vs. HQY: Which Stock Is the Better Value Option? Investors interested in Medical Services stocks are likely familiar with Pediatrix Medical Group (MD) and HealthEquity (HQY). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com - 1 month ago
8. Profile Summary

Pediatrix Medical Group, Inc. MD

image
COUNTRY US
INDUSTRY Medical - Care Facilities
MARKET CAP $ 1.23 B
Dividend Yield 0.00%
Description Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of February 17, 2022, it operated a network of approximately 2,700 physicians. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
Contact 1301 Concord Terrace, Sunrise, FL, 33323 https://www.mednax.com
IPO Date Sept. 20, 1995
Employees 4120
Officers Ms. Kasandra H. Rossi Executive Vice President, Treasurer & Chief Financial Officer Mr. John C. Pepia Senior Vice President & Chief Accounting Officer Ms. Cheryl M. VanPatten Senior Vice President & Chief Information Officer Mr. Mark S. Ordan Chief Executive Officer & Executive Chairman Ms. Nanette Sanders Senior Vice President of Operations Ms. Debra McRoberts Senior Vice President of People Services Ms. Mary Ann E. Moore J.D. Chief Administrative Officer, Executive Vice President, General Counsel & Secretary Mr. Daniel Patrick Corcoran Senior Vice President of Administration & Managed Care Mr. Mike Ashford President of South Central Division Mr. Kevin Pitzer President of West Division